18f dpa-714 Report issue

Small molecule Imaging Experimental
AACT

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: CCN(CC)C(=O)Cc1c(-c2ccc(OCC[18F])cc2)nn2c(C)cc(C)nc12
  • InChIKey: FLZZFWBNYJNHMY-VNRZBHCFSA-N
  • Mol. Mass: 397.48
  • ALogP: 3.77
  • ChEMBL Molecule:
    [18f]dpa-714  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Imaging: 18-fluorine
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

18f dpa-714 | 18f-dpa-714

Organizations (12)

Research & Development (12)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (20)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (20)


 

Alzheimer Disease (Phase 1)

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 1)

Carotid Arteries (Phase 1)

Carotid Stenosis (Phase 2)

Cognitive Dysfunction (Phase 1)

Diagnostic Imaging (Phase 1)

Epilepsy, Post-Traumatic (Phase 1)

Fatigue Syndrome, Chronic (Phase 1)

Fibromyalgia (Phase 1)

Healthy Volunteers (Phase 1)

Idiopathic Pulmonary Fibrosis (Phase 1)

Medulloblastoma (Phase 2)

Memory Disorders (Phase 1)

Multiple Sclerosis (Phase 1)

Myocardial Infarction (Phase 1)

Ovarian Neoplasms (Phase 1)

Parkinson Disease (Phase 2)

Severe acute respiratory syndrome-related coronavirus (Early Phase 1)

Triple Negative Breast Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 18
  • # of Trial Organizations: 12

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue